Position
VAN ECK ASSOCIATES CORP in Sarepta Therapeutics, Inc.
Back to the book · All holders of SRPT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $3$0.02 → $0.02
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 12.3K | $264 | — | — | — | 0.0% |
| Q1 2026 | 12.1K | $263 | $0.02 | $3 | −$4 | 0.0% |